Impact of 13-valent pneumococcal conjugate vaccine on the incidence of hospitalizations for all-cause pneumonia among children aged less than 5 years in Burkina Faso: an interrupted time-series analysis
Pneumococcal disease is characterized by diverse clinical manifestations, but the overall burden is dominated by pneumonia which accounted for 15% of all pediatric deaths in 2017 (World Health Organization, 2019). Furthermore, up to 81% of pneumonia deaths occur in the first two years of life and nearly all pneumonia deaths are recorded in low- and middle-income countries, with Sub-Saharan Africa bearing a great share of pneumonia burden (43% of global pneumonia deaths)(Walker et al., 2013). In 2016, pneumonia was the third most frequent cause of visit to hospital outpatient clinics in Burkina Faso, representing 5 ·4% of all visits (Ministère de la Santé (Burkina Faso), 2017).
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: L. Kabor é, S. Ouattara, F. Sawadogo, A. Gervaix, A. Galetto-Lacour, R. Karama, A.T. Traoré, B. Méda, H. Tall, T.A. Essoh, B.D. Gessner, J.C. Moïsi Source Type: research
More News: African Health | Burkina Faso Health | Children | Hospitals | Infectious Diseases | International Medicine & Public Health | Meningitis Vaccine | Pediatrics | Pneomococcal Vaccine | Pneumonia | Vaccines | WHO